Experts are let down with the outcomes of a research study of the firm’s excessive weight medication prospect Cagrisema for numerous factors.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/novo-nordisk-evp-pleased-with-new-obesity-data-despite-price-drop/